KEW Stock Overview
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 6/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Kewaunee Scientific Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$35.80 |
52 Week High | US$35.80 |
52 Week Low | US$28.00 |
Beta | 0.73 |
11 Month Change | 18.54% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 26.95% |
Recent News & Updates
Recent updates
Shareholder Returns
KEW | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 7.2% | -4.5% | -0.6% |
1Y | n/a | -3.2% | 9.6% |
Return vs Industry: Insufficient data to determine how KEW performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how KEW performed against the German Market.
Price Volatility
KEW volatility | |
---|---|
KEW Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: KEW's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine KEW's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1906 | 1,006 | Thomas Hull | www.kewaunee.com |
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Kewaunee Scientific Corporation Fundamentals Summary
KEW fundamental statistics | |
---|---|
Market cap | €104.62m |
Earnings (TTM) | €17.57m |
Revenue (TTM) | €192.44m |
5.9x
P/E Ratio0.5x
P/S RatioIs KEW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KEW income statement (TTM) | |
---|---|
Revenue | US$202.31m |
Cost of Revenue | US$149.68m |
Gross Profit | US$52.63m |
Other Expenses | US$34.15m |
Earnings | US$18.47m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.43 |
Gross Margin | 26.01% |
Net Profit Margin | 9.13% |
Debt/Equity Ratio | 54.9% |
How did KEW perform over the long term?
See historical performance and comparison